Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [TECHNOLOGY]

4 clusters · 21 sources · 21 days · First seen 24 days ago · Last updated 3 days ago

FDA authorization of Aletta robotic blood draw device

Overview

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization to Aletta, an autonomous robotic system developed by the Dutch company Vitestro for performing blood draws on adult patients in outpatient settings. The device is designed to address shortages of trained phlebotomists and nursing staff.

Aletta uses near-infrared light and Doppler ultrasound to identify suitable veins while distinguishing them from arteries. If the system cannot identify a safe vein, it will not attempt the procedure. Once a target is located, the robot autonomously manages the application of a tourniquet, skin preparation, needle insertion, tube changes, and bandaging. Clinical data indicates the robot is at least as efficient as a human operator, with success rates comparable to or exceeding those of professional technicians across diverse patient populations and skin tones.

While the system operates autonomously, it requires supervision by a trained healthcare professional. A single phlebotomist or nurse is permitted to oversee up to three Aletta devices simultaneously, with responsibilities including initiating the session, monitoring the process, and verifying that collection tubes are filled correctly.

Following the authorization, labor organizations such as UGL Salute have cautioned that robotics should serve as a “support tool rather than a replacement for healthcare professionals.”

Despite the regulatory milestone, Aletta will not be immediately available to U.S. patients. Vitestro plans to deploy the technology in Europe first and intends to conduct multicenter clinical trials in the United States to validate performance in American clinical settings before a full commercial launch.

Entities

Vitestro · Aletta · FDA · Michelle Tarver · Ugl Salute

Timeline

3 days ago

[TECHNOLOGY] 2 sources
Vitestro’s Aletta receives FDA authorization for autonomous blood collection
The FDA has authorized Vitestro’s Aletta, the first autonomous robot capable of drawing blood without hands-on intervention. Deployment will begin in Europe before entering the U.S. market.
19 days ago

[TECHNOLOGY] 10 sources
FDA authorizes Aletta robotic blood draw device
The FDA has authorized Aletta, a robotic device by Vitestro, to perform autonomous blood draws in the US, aiming to assist healthcare workers facing staffing shortages.
21 days ago

[TECHNOLOGY] 6 sources
FDA approves Aletta robotic system for autonomous blood draws
The FDA has approved Vitestro’s Aletta, an autonomous robot that uses infrared light and ultrasound to locate veins and perform blood draws under the supervision of a trained professional.
24 days ago

[HEALTH] 3 sources
FDA authorizes Aletta robotic blood draw device
The FDA has authorized Aletta, a robotic device that autonomously performs blood draws, aiming to alleviate the shortage of trained phlebotomists in outpatient settings.

Sources

2minutemedicine.com · aeiou.pt · antennasud.com · consultorsalud.com · epochtimes.com · expartibus.it · geekyalgeria.com · go4it.ro · insalutenews.it · mediafax.ro · medicaldaily.com · medlabnews.gr · myfoxatlanta.com · news20.ro · nursetimes.org · quisalute.online · sapo.pt · showmetech.com.br · stiripesurse.ro · tromaktiko.gr · upday.com

This summary has been updated 4 times: see revision history